ExactScience

Free

Transforming Cancer Care Through Personalized Diagnostics

#molecular diagnostics#cancer care#prevention#early detection#treatment guidance#non-invasive screening tests#colorectal cancer#genomic profiling#hereditary cancer risk#multi-cancer early detection#innovation#scientific validation#clinical guidelines

Starting Price

$99/mo

Type

Saas

Company

ExactScience

Visit Website

LinksX LinkedIn

About ExactScience

ExactScience is an AI-enabled rank tracking software designed for SEO professionals and enterprise businesses. It tracks real SERPs at scale, providing context-aware SERP tracking, content relevance scoring, and history tracking. The platform centralizes brand management, offers exportable data, customizable updates, and integrates with Google Search Console to enhance ranking analysis.

How to Use

Users can sign up for a free trial or a paid plan, connect their domains, input keywords, and track their rankings across various SERP elements. The platform provides tools to analyze ranking history, content relevance, and competitive metrics.

Key Features

AI-Enabled Rank Intelligence
Content Relevance Score
Historical Rank Tracking
Google Search Console Integration
Competitive Insights
Customizable Refresh Frequency
Slack Alerts for Major Rank Changes

Use Cases

Track keyword rankings for multiple brands and competitors in one place.
Identify revenue-impacting keywords to target using search volume, CPC bids, and competitive index data.
Monitor time-sensitive articles showing up in top stories for publishers.
Track performance by grouping keywords with tags based on website sections, content topics, or buyer's journey stages.

Key Features

Comprehensive suite of cancer tests across the care continuum, including early detection and screening.

Offers Cologuard®, a non-invasive at-home stool DNA test for colorectal cancer screening.

Develops blood tests like Oncoguard® Liver for early detection of hepatocellular carcinoma and Riskguard™ for hereditary cancer risk assessment.

Provides advanced tests still in development, such as Cancerguard™ for multiple cancer detection.

Treatment guidance through tests like Oncotype DX Breast and Colon Recurrence Scores for assessing cancer recurrence and therapy benefits.

OncoExTra® test for aiding late-stage cancer therapy selection.

Supports patient and provider through logins for test ordering and results tracking.

Backed by extensive scientific research, publications, and clinical studies.

Engages in community outreach and health equity initiatives.

Pros & Cons

Pros

AI-powered context-aware tracking provides accurate ranking data beyond standard blue links.
Content Relevance Score helps optimize page content for target keywords.
Credit system prevents duplicate charges for same keyword across multiple domains.
Unlimited domains, competitors, tags, exports, and users across paid plans.
Flexible refresh frequencies to match reporting cadence.
Free 7-day trial with 30 keywords and no credit card required.

Cons

Pricing can become expensive for high-frequency updates (e.g., 15-minute refresh) due to credit consumption.
Credit-based system may require careful budgeting and planning.
No explicit integration with Google Search Console or other analytics platforms mentioned on the site.
Relatively new tool with potentially smaller user base and community support.

Best For

Healthcare providers: Utilize Cologuard® to screen patients for colorectal cancer in a non-invasive manner.Oncologists: Guide treatment decisions for breast and colon cancer patients using Oncotype DX®.Patients with liver conditions: Early detection of liver cancer with Oncoguard® Liver test.Genetic counselors: Assess hereditary cancer risk with Riskguard™ for personalized patient guidance.Cancer researchers: Explore opportunities in blood-based multi-cancer early detection technologies.Healthcare administrators: Integrate Exact Sciences' tests into clinical workflows using ExactNexus™ technology.Primary care physicians: Incorporate multi-cancer detection for preventive health measures.Insurance companies: Evaluate coverage options for innovative cancer diagnostic tests.Healthcare IT specialists: Facilitate seamless result reporting and electronic ordering processes.Medical conference organizers: Showcase cutting-edge cancer diagnostic research and advancements.